Arcadia Biosciences, Inc.
corporate_fare Company Profile
Arcadia Biosciences, Inc. (NASDAQ:RKDA) is a publicly traded company in the Energy & Transportation sector. Wiseek has independently scored 23 items for RKDA at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Two Directors Resign from Arcadia Biosciences Board Amidst Capital Raising Efforts
- Arcadia Biosciences Files for Resale of Shares Representing Over 100% Potential Dilution Amid Going Concern Warning
- Arcadia Biosciences Raises $2.1M via Deeply Discounted Option Exercise and New Dilutive Options
Financial Snapshot
Fiscal year ended December 31, 2025
Revenue
$4.86M
Net Income
-$2.34M
Diluted EPS
-$1.71
Op. Cash Flow
-$4.74M
Free Cash Flow
-$4.74M
Gross Profit
$1.76M
Operating Income
-$2.5M
Cash & Equivalents
$259K
Debt / Equity
0.00×
Net Margin
-48.1%
Shares Outstanding
1.37M sh
Source: 10-K · filed 2026-04-30 · accession 0001193125-26-197315
show_chartPrice Chart
Loading chart...
feed RKDA - Filings & News (Page 2)
RKDA
Feb 06, 2026, 4:03 PM EST
Price at Filing:
$1.80
Real-time Price:
$0.1555
Change:
-$1.64 (-91%)
Market Cap:
$373.428K
RKDA
Jan 27, 2026, 8:45 PM EST
Price at Filing:
$2.23
Real-time Price:
$0.1555
Change:
-$2.07 (-93%)
Market Cap:
$373.428K
RKDA
Jan 13, 2026, 8:07 PM EST
Price at Filing:
$2.55
Real-time Price:
$0.1555
Change:
-$2.39 (-94%)
Market Cap:
$373.428K